Latest Articles

Publication Date
Reproductive outcomes in infertile women with endometriosis undergoing ART.

Background Endometriosis-related infertility and its treatment with assisted reproductive technologies (ART) have been broadly researched. Yet, underlying mechanisms of infertility, particularly in the absence of tubal dysfunction, remain unclear. While …

Published: Jan. 25, 2025, midnight
Allara Health Secures $26M to Advance Women’s Hormonal Care - MedCity News

Allara Health Secures $26M to Advance Women’s Hormonal Care MedCity News

Published: Jan. 24, 2025, 10:25 p.m.
Allara Health Raises $26 Million in Series B Funding to Revolutionize Women's Hormonal Healthcare - The Malaysian Reserve

Allara Health Raises $26 Million in Series B Funding to Revolutionize Women's Hormonal Healthcare The Malaysian Reserve

Published: Jan. 24, 2025, 3:34 p.m.
Allara Health raises $26 million Series B for hormonal health virtual care platform - substack.com

Allara Health raises $26 million Series B for hormonal health virtual care platform substack.com

Published: Jan. 24, 2025, 3:09 p.m.
Allara Health Raises $26M Series B to Scale Virtual Hormonal Healthcare Platform - Femtech Insider

Allara Health Raises $26M Series B to Scale Virtual Hormonal Healthcare Platform Femtech Insider

Published: Jan. 24, 2025, 2:53 p.m.
Allara Health Raises $26 Million in Series B Funding to Revolutionize Women's Hormonal Healthcare - StreetInsider.com

Allara Health Raises $26 Million in Series B Funding to Revolutionize Women's Hormonal Healthcare StreetInsider.com

Published: Jan. 24, 2025, 2:47 p.m.
Pathogenesis, Diagnosis, and Management of Inguinal Endometriosis: A Case Series of Six Patients.

Inguinal endometriosis is a less common form of endometriosis. Therefore, there is no consensus regarding its pathogenesis or treatment. In this study, we retrospectively reviewed the pathogenesis and treatment of …

Published: Jan. 24, 2025, midnight
Identification of potential druggable targets for endometriosis through Mendelian randomization analysis.

Endometriosis (EM) is a widely recognized disorder in gynecological endocrinology. Although hormonal therapies are frequently employed for EM, their side effects and outcome limitations underscore the need to explore the …

Published: Jan. 22, 2025, midnight
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Jan. 20, 2025, 10:56 a.m.
A cRGD-modified liposome for targeted delivery of artesunate to inhibit angiogenesis in endometriosis.

Currently, hormonal therapy for endometriosis faces challenges in achieving a balance between treatment and preserving the chance of pregnancy. Therefore, the development of non-hormonal therapy holds significant clinical importance. Angiogenesis …

Published: Jan. 20, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!